scispace - formally typeset
Search or ask a question

Answers from top 15 papers

More filters
Papers (15)Insight
Hematopoietic stem cell transplant is cheaper in India as compared to developed countries and there is a huge cost difference.
Open accessJournal ArticleDOI
George Kolios, Yuben Moodley 
01 Jan 2013-Respiration
298 Citations
Stem cells can be used in cellular therapy to replace damaged cells or to regenerate organs.
In total, the intervention saved 19,055 USD, i. e., at a price of 19,055 USD for stem cells, the SCT would be cost neutral.
Socio-economic implications of such results must be evaluated, especially since the development of peripheral hematopoietic stem cells will reduce both toxicity and cost.
The cost of this procedure in India is many times lower than that in the developed countries and more and more centres are now offering BMT and autologous stem cell transplantation to both the local population as well as medical tourists.
In conclusion, both tissues can be cultured and preserve their stem cells in vitro.
We can avoid this outcome—although at a cost—by carefully selecting the stem cells we make available.
Innovations in stem cell therapy in India can make treatments more affordable to address the needs of in-country patients.
In conclusion, results provided by the present study suggest the need to develop novel culture protocols able to preserve stem cell plasticity.
Although stem cells obtained from an adult organism have smaller capabilities for differentiation in comparison to embryonic and induced pluripotent stem cells (iPSs), the cost of obtaining them is significantly lower.
This follows concern that India could emerge as a major source of embryonic stem cells as there is almost no public or religious debate …
In addition, process efficiency is crucial for ensuring cost efficiency, especially when considering large‐scale production of mesenchymal stem cells (MSCs).
A desirable recovery method for stem cells has to guarantee high purity and should be sensitive, rapid, quantitative, scalable, non- or minimally invasive to preserve viability and differentiation capacity of the purified cells.
However, an efficient cell expansion method that is reliable and cost-effective is warranted to provide off-the-shelf clinical grade stem cells.
It is anticipated that the optimization of large-scale cell culture as performed for other stem cells can be translated into successful protocols for bovine satellite cells resulting in resource and cost efficient cultured beef.